NUVEEN YORK SELECT TAX-FREE INCME PORTFOLIO
NUVEEN YORK SELECT TAX-FREE INCME PORTFOLIO
Share · US65342G2030 (XNYS)
Overview
No Price
n/a
Company Profile for NUVEEN YORK SELECT TAX-FREE INCME PORTFOLIO Share
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.
Get up to date insights from finAgent about NUVEEN YORK SELECT TAX-FREE INCME PORTFOLIO

Company Data

Name NUVEEN YORK SELECT TAX-FREE INCME PORTFOLIO
Company Nexeon MedSystems Inc.
Website https://www.nexeonmedsystems.com
Primary Exchange XNYS NYSE
ISIN US65342G2030
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO William Rosellini
Country United States of America
Currency USD
Employees 0,1 T
Address 1910 Pacific Avenue, 75201 Dallas
IPO Date 2017-09-27

Ticker Symbols

Name Symbol
Over The Counter NXNN
More Shares
Investors who hold NUVEEN YORK SELECT TAX-FREE INCME PORTFOLIO also have the following shares in their portfolio:
CHESAPEAKE ENERGYCORP - CLASS B WARRANTS
CHESAPEAKE ENERGYCORP - CLASS B WARRANTS Share
ITALIEN 19/40
ITALIEN 19/40 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025